Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (271-280 of 295) with videos related to

Pageof 30
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 17, 2025
Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotypeZachary A Miller, Rik Ossenkoppele, Neill R Graff-Radford, et al.
Neurology|July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic CarriersEmma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Neurology|April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory ClinicColin Groot, Ismael L Calandri, Ilse Bader, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to actionNick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 10, 2024
Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort studyHulya Ulugut, Maxime Bertoux, Kyan Younes, et al.
Pageof 30

Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 17, 2025
Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotypeZachary A Miller, Rik Ossenkoppele, Neill R Graff-Radford, et al.
Neurology|July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic CarriersEmma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
Neurology|April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory ClinicColin Groot, Ismael L Calandri, Ilse Bader, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2026
Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to actionNick Corriveau-Lecavalier, Neus Falgàs, Deepti Putcha, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 10, 2024
Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort studyHulya Ulugut, Maxime Bertoux, Kyan Younes, et al.
Pageof 30